Evidence map›Paper›PMID 40303794›Full record

ArticleTransboundary and emerging diseases2023

SARS-CoV-2 Neutralizing Antibodies in Free-Ranging Fallow Deer (

Paloma Encinas, Alba Escalera, Teresa Aydillo, Irene Iglesias, Martha I Nelson, Adolfo García-Sastre, Gustavo Del Real

Abstract read
In one paragraph

Article in Transboundary and emerging diseases, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Early Fc-effector antibody signatures impact COVID-19 disease trajectory.medRxiv : the preprint server for health sciences · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Paloma EncinasDepartment of Biotechnology, National Institute of Agricultural and Food Research and Technology (INIA/CSIC), Madrid, Spain.ORCID https://orcid.org/0000-0001-9596-8070
Alba EscaleraDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.ORCID https://orcid.org/0000-0003-0061-0768
Teresa AydilloDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.ORCID https://orcid.org/0000-0003-3086-1058
Irene IglesiasCenter for Animal Health Research, INIA-CISA/CSIC, Valdeolmos, Madrid, Spain.ORCID https://orcid.org/0000-0003-3472-6873
Martha I NelsonNational Center for Biotechnology Information, National Library of Medicine, National Institutes of Health, Bethesda, MD, USA.ORCID https://orcid.org/0000-0003-4814-0179
Adolfo García-SastreDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.ORCID https://orcid.org/0000-0002-6551-1827
Gustavo Del RealDepartment of Biotechnology, National Institute of Agricultural and Food Research and Technology (INIA/CSIC), Madrid, Spain.ORCID https://orcid.org/0000-0003-1146-8074

Funding

NIAID Centers of Excellence for Influenza Research and Response: Universal Influenza Vaccine Research Activities75N93021C00014 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI GARCIA-SASTRE, ADOLFO · 2021 to 2025
$62.6M
NIAID NIH HHS 75N93021C00014
6 · The paper itself

Abstract

Effective control of zoonotic infectious diseases requires identifying the animal species involved in the infectious cycle as transmitters or reservoirs where the pathogen could persist and evolve, increasing the risk of reintroduction of new variants in humans and animals. Multiple surveillance studies have detected the presence of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) or specific antibodies in free-ranging white-tailed deer (

Indexed as

Antibodies, NeutralizingAntibodies, ViralCOVID-19DeerSARS-CoV-2AnimalsAnimals, WildSpainAntibodies, NeutralizingAntibodies, Viral

Identifiers

PMID40303794
PMCPMC12017049

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.